Statistics
Publications
2
Citations
31
H-Index
2
Active since
2020
Affiliations
Merck KGaA, Darmstadt (Germany)(Current)
Doreen Musch is an author at Merck KGaA, Darmstadt (Germany) specializing in oncology, cancer genetics, and cancer progression.
Publications per year
2020–2023
2
2
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations
Linda Pudelko, Frank Jaehrling, Christof Reusch et al. · iScience · 2020 · 21 citations · Full text
Medicine, Oncology, Pharmacology +17
Overcoming MET-mediated resistance in oncogene-driven NSCLC
Nadine Reischmann, Carolin Schmelas, Miguel Ángel Molina‐Vila et al. · iScience · 2023 · 10 citations · Full text
1–2 of 2